IRCT20210519051345N27招募中未知
Bioequivalence study of Anagrelide 0.5mg capsule manufactured by Ronak Co. compared with innovator product
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
排除标准
- •History of cardiovascular disease, liver and kidney diseases
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
Unknown
Anagrelide capsule BioequivalenceIRCT20130313012810N30Modava Pharmaceutical Company24
尚未招募
Unknown
Investigating the in vivo bioequivalence of Anagrelide 0.5 mg capsuleIRCT20210519051345N60Tabriz University of Medical Sciences24
已完成
不适用
Bioequivalence study of Agomelatine 25 mg in healthy volunteer under fasting conditioBioequivalence study of agomelatine 25 mgTCTR20200903006nison Laboratories Co., Ltd.36
尚未招募
4 期
Bioequivalence study of pregabalin 25 mg capsule in Thai healthy volunteers-Thai healthy male and female subjects-Aged 18 †50 years -BMI were within 18ᆭ kg/m2-Good health confirming by physical and clinicabioequivalence,pharmacokinetic,pregabalinTCTR20161117001Ratchadapisek Sompoj Fund, Chulalongkorn University24
已完成
1 期
Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mgHealthyNCT00648024Mylan Pharmaceuticals Inc47